Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27657695 | 1.00 | ALDH1A1 (0.50) | ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2 | |
| SCHEMBL27969690 | 0.84 | MEN1 (0.51) | ALDH1A1KMT2ASMN1; SMN2MEN1NPC1 | |
| SCHEMBL15012156 | 0.84 | MEN1 (0.51) | ALDH1A1KMT2ASMN1; SMN2MEN1NPC1 | |
| SCHEMBL883026 | 0.82 | SLC16A3 (0.55) | ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2 | |
| SCHEMBL11475913 | 0.82 | ALDH1A1 (0.52) | ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2 | |
| SCHEMBL5326821 | 0.81 | MMP8 (0.52) | ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2 | |
| SCHEMBL4952574 | 0.80 | ALDH1A1 (0.48) | ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2 | |
| SCHEMBL1356758 | 0.79 | TSHR (0.48) | ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2 | |
| SCHEMBL2000765 | 0.79 | ALDH1A1 (0.48) | ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2 | |
| SCHEMBL27564805 | 0.79 | ALDH1A1 (0.48) | ALDH1A1KMT2AMAPK1L3MBTL1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1919865-A | Bioactivity peptide, preparing process and application thereof | OCEAN UNIV CHINA (CN) | 2007-02-28 | — | — | CN | claimed |
| US-12552738-B2 | Crystal forms of amino lipids | MODERNATX, INC. (US) | 2026-02-17 | — | — | US | disclosed |
| US-20220073449-A1 | CRYSTAL FORMS OF AMINO LIPIDS | ARES CAPITAL CORPORATION, AS AGENT | 2022-03-10 | — | — | US | disclosed |
| CN-1919865-A | Bioactivity peptide, preparing process and application thereof | OCEAN UNIV CHINA (CN) | 2007-02-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220073449-A1 | CRYSTAL FORMS OF AMINO LIPIDS | STARD3, PLIN3, ELOVL3 | ALDH1A1 4814/4885KMT2A 1270/4885MAPK1 2335/4885 |
| US-12552738-B2 | Crystal forms of amino lipids | SFN, SCD, EBP | ALDH1A1 4778/4885KMT2A 935/4885MAPK1 1959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.